| Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature Medicine 29 (10), 2438-2457, 2023 | 48 | 2023 |
| Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study JM Dennis, KG Young, AP McGovern, BA Mateen, SJ Vollmer, ... The Lancet Digital Health 4 (12), e873-e883, 2022 | 20 | 2022 |
| Prevalence of Fabry disease-causing variants in the UK Biobank M Gilchrist, F Casanova, JS Tyrrell, S Cannon, AR Wood, N Fife, K Young, ... Journal of Medical Genetics, 2022 | 15 | 2022 |
| Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches NJ Thomas, A McGovern, KG Young, SA Sharp, MN Weedon, ... Journal of Clinical Epidemiology 153, 34-44, 2023 | 14 | 2023 |
| The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis KG Young, AP McGovern, I Barroso, AT Hattersley, AG Jones, BM Shields, ... Diabetologia 66 (2), 300-309, 2023 | 8 | 2023 |
| Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and … KG Young, TJ McDonald, BM Shields International Journal of Epidemiology 51 (3), 1022-1024, 2022 | 8 | 2022 |
| Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study … JM Dennis, KG Young, AP McGovern, BA Mateen, SJ Vollmer, ... medRxiv, 2021.11. 11.21265959, 2021 | 8 | 2021 |
| Reconfigurable T‐junction DNA origami KG Young, B Najafi, WM Sant, S Contera, AA Louis, JPK Doye, ... Angewandte Chemie International Edition 59 (37), 15942-15946, 2020 | 6 | 2020 |
| Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review KG Young, EH McInnes, RJ Massey, AR Kahkoska, SJ Pilla, S Raghavan, ... Communications Medicine 3 (1), 131, 2023 | 5 | 2023 |
| Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors KG Young, EH McInnes, RJ Massey, AR Kahkohska, SJ Pilla, ... medRxiv, 2023 | 5 | 2023 |
| Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a … AH Heald, S Martin, H Fachim, HD Green, KG Young, N Malipatil, ... Diabetic Medicine 38 (9), e14531, 2021 | 3 | 2021 |
| Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes P Cardoso, KG Young, ATN Nair, R Hopkins, AP McGovern, E Haider, ... Diabetologia, 1-15, 2024 | 1 | 2024 |
| Safety and effectiveness of SGLT2-inhibitors in people with type 2 diabetes over 70: UK population-based study using an Instrumental Variable approach LM Guedemann, KG Young, NJM Thomas, R Hopkins, R Challen, ... medRxiv, 2024.01. 04.24300832, 2024 | 1 | 2024 |
| HbA (1c) screening in 195,460'non-diabetic'individuals (40-69 years) identifies 1.1% with undiagnosed diabetes 2 years before clinical diagnosis KG Young, NJ Thomas, AG Jones, A McGovern, BM Shields, I Barroso, ... DIABETOLOGIA 63 (SUPPL 1), S166-S166, 2020 | 1 | 2020 |
| Characterising DNA T-motifs by Simulation and Experiment B Najafi, KG Young, J Bath, AA Louis, JPK Doye, AJ Turberfield arXiv preprint arXiv:2005.11545, 2020 | 1 | 2020 |
| Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach LM Güdemann, KG Young, NJM Thomas, R Hopkins, R Challen, ... Diabetologia, 1-11, 2024 | | 2024 |
| Challenges of detecting childhood diabetes in primary care KG Young, JM Dennis, NJM Thomas The Lancet Digital Health 6 (6), e375-e376, 2024 | | 2024 |
| The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records AC Gillett, SP Hagenaars, D Handley, F Casanova, KG Young, H Green, ... BMC medicine 22 (1), 211, 2024 | | 2024 |
| An international, multidisciplinary consensus set of patient-centered outcome measures for substance-related and addictive disorders N Black, S Chung, C Tisdale, LS Fialho, A Aramrattana, ... Journal of clinical medicine 13 (7), 2154, 2024 | | 2024 |
| Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study R Hopkins, KG Young, NJ Thomas, J Godwin, D Raja, BA Mateen, ... BMJ open 14 (1), e078135, 2024 | | 2024 |
